July 2012 – Actos pulled off the market in France after study links the drug to an increased risk for bladder cancer.
July 2012 – Pulled off the market
Announcement Date: July 1, 2012
July 2012 – Actos pulled off the market in France after study links the drug to an increased risk for bladder cancer.